A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Dextroamphetamine (DEXEDRINE)

Dextroamphetamine treats ADHD and narcolepsy by increasing dopamine and norepinephrine activity.

First FDA approval1976-08-02
Generic availableYes · 11 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$15.3M in CY2024 Part D spend145K claims · 29K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.442/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.595
Across all dosage forms in distribution.
Highest NADAC
$1.19
Range is tight.
Plans with PA
7 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Dextroamphetamine used for?

Dextroamphetamine treats ADHD and narcolepsy by increasing dopamine and norepinephrine activity.

Is there a generic for Dextroamphetamine?

Yes. 34 ANDAs filed at FDA, 11 generic manufacturers currently shipping.

How much does my plan pay for Dextroamphetamine?

Across 329 Part D plans, Dextroamphetamine averages $0.595/unit (NADAC). Lowest available: $0.442/unit. Highest in distribution: $1.19/unit.

Is Dextroamphetamine on the FDA shortage list?

No. Dextroamphetamine is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Central Nervous System Stimulant6 alternatives in D1
01
Acetaminophen, Caffeine, Dihydrocodeine Bitartrate
Brand: Trezix
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Amphetamine
Brand: Adzenys XR-ODT
$0.350Lowest NADAC
12Generic mfrs
$3.0MCY24 Part D spend
Compare →
03
Amphetamine Extended-Release
Central Nervous System Stimulant
$16.31Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Caffeine
Brand: CAFCIT
Lowest NADAC
6Generic mfrs
CY24 Part D spend
Compare →
05
Caffeine and Sodium
Central Nervous System Stimulant
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
06
Dexmethylphenidate
Brand: Focalin
$0.217Lowest NADAC
13Generic mfrs
$9.7MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.